Walleye Trading
SAGE

Walleye Trading’s Sage Therapeutics SAGE Stock Holding History

Walleye Trading’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-42,376
Closed -$386K – 4758
2025
Q2 		$386K Buy
+42,376
New +$312K ﹤0.01% 2820
2024
Q1 		– Sell
-7,561
Closed -$164K – 5267
2023
Q4 		$164K Sell
7,561
-8,443
-53% -$167K ﹤0.01% 3901
2023
Q3 		$329K Buy
16,004
+10,283
+180% +$297K ﹤0.01% 3298
2023
Q2 		$269K Buy
+5,721
New +$285K ﹤0.01% 3240
2021
Q2 		– Sell
-3,465
Closed -$245K – 5497
2021
Q1 		$259K Buy
+3,465
New +$284K ﹤0.01% 3392
2020
Q2 		– Sell
-5,736
Closed -$208K – 4559
2020
Q1 		$165K Buy
+5,736
New +$332K ﹤0.01% 2772
2019
Q4 		– Sell
-4,801
Closed -$591K – 4573
2019
Q3 		$674K Buy
4,801
+2,185
+84% +$366K 0.01% 1904
2019
Q2 		$479K Buy
+2,616
New +$446K ﹤0.01% 2228
2016
Q1 		– Sell
-608
Closed -$35K – 5765
2015
Q4 		$35K Buy
+608
New +$30.1K ﹤0.01% 4094

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Walleye Trading's SAGE Position: Q3 2025 in Review

Walleye Trading sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 42,376 shares — an estimated $386K sold.

Walleye Trading first reported a position in SAGE in Q4 2015 and held it in 9 quarters. The position peaked at $674K in Q3 2019. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • Walleye Trading reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Walleye Trading sold 42,376 Sage Therapeutics shares in Q3 2025, an estimated $386K.
  • Walleye Trading first reported a position in Sage Therapeutics in Q4 2015 and held it in 9 quarters.
  • Walleye Trading's Sage Therapeutics position peaked at $674K in Q3 2019.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on Walleye Trading's 13F filing for Q3 2025, filed 14 Nov 2025.